Economy

Is Proto Labs, Inc. (NYSE:PRLB) Worth a Second Glance With a PCF of 41.828391?

The Price to book ratio is the current share price of a company divided by the book value per share.  The Price to Book ratio for Proto Labs, Inc. NYSE:PRLB is 8.397686.  A lower price to book ratio indicates that the stock might be undervalued.  Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value.  […]

Pulling Back the Curtain on These Stocks: Digital Turbine, Inc. (NasdaqCM:APPS), INSYS Therapeutics, Inc. (NasdaqGM:INSY)

Taking a look at some key metrics and ratios for Digital Turbine, Inc. (NasdaqCM:APPS), we note that the ROA or Return on Assets stands at -0.434714. Return on Assets shows how many dollars of earnings result from each dollar of assets the company controls. Return on assets gives an indication of the capital intensity of the company, which will also depend on […]

Mastech Digital, Inc. (AMEX:MHH), DISH Network Corporation (NasdaqGS:DISH) Return on Assets in Focus & Quant Signal Update

In trying to determine how profitable a company is per asset dollar, we can take a look at  the firm’s Return on Assets.  Return on assets is calculated by dividing a company’s net income (usually annual income) by its total assets, and is displayed as a percentage. At the time of writing, Mastech Digital, Inc. (AMEX:MHH) has 0.119248 ROA.  The measure is commonly used to compare the […]

Beasley Broadcast Group, Inc. (NasdaqGM:BBGI), Cognex Corporation (NasdaqGS:CGNX): Quant Scorecard Under the Microscope

In trying to determine how profitable a company is per asset dollar, we can take a look at  the firm’s Return on Assets.  Return on assets is calculated by dividing a company’s net income (usually annual income) by its total assets, and is displayed as a percentage. At the time of writing, Beasley Broadcast Group, Inc. (NasdaqGM:BBGI) has 0.122918 ROA.  The measure is commonly used to compare […]

Stock Review: Zooming in on Shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT)

Monitoring recent stock price movement on shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT) we have recorded the stock price at $27.72. Investors may be intently tracking price activity on the stock over the next few sessions, and looking for any signs of a possible shift in momentum. Let’s focus in on some historical trading information. Over the last 12 week period, […]